FAQ: The High Cost of Hepatitis C Drugs

Published April 25, 2014

FAQ: The High Cost of Hepatitis C Drugs
April 14, 2014 — Last week, the World Health Organization strongly endorsed two new oral drugs that fight hepatitis C, a liver-damaging virus. The WHO recommended that all 150 million people infected worldwide be assessed for these drug treatments.
Read more on WebMD

UnitedHealth: New hepatitis C drug costs far more than forecast
This has focused scrutiny on U.S. drug prices, which outstrip the rest of the world. Biotechnology shares were already in the midst of a selloff when U.S. lawmakers asked on March 21 for Gilead Sciences to explain the price for the Sovaldi treatment.
Read more on Reuters

Find More Cost Of Drug Treatment Information…